The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

President Donald Trump announced on Friday a deal with drugmaker AstraZeneca in his latest effort to lower drug costs through so-called “Most Favored Nation” pricing. The move comes after the ...

AstraZeneca — the British pharmaceutical giant that famously rebuffed a $118 billion hostile takeover from Pfizer in 2014 by pledging to remain fiercely independent — is now reportedly pursuing a ...

Last week, AstraZeneca became the second pharmaceutical company to reach a deal to join the White House's most favored nation (MFN) prescription drug pricing program, a policy initiative designed to ...

Oncology sales comprise around 27% of its total revenues. In the second quarter of 2026, oncology revenues increased 3% to $4 ...

Pfizer PFE and AstraZeneca AZN are two global pharmaceutical leaders with a commanding presence in oncology. For Pfizer, oncology is a key growth driver, accounting for roughly 27% of total company ...

Pfizer PFE and AstraZeneca AZN are global pharmaceutical leaders with a strong presence in oncology. For Pfizer, oncology is a major growth driver, contributing about 27% of total revenues. Beyond ...